ATE238047T1 - Verwendung von n,n-bis (phenylcarbamoylmethyl) dimethylammoniumchlorid und derivaten davon zur behandlung von chronischem schmerz - Google Patents

Verwendung von n,n-bis (phenylcarbamoylmethyl) dimethylammoniumchlorid und derivaten davon zur behandlung von chronischem schmerz

Info

Publication number
ATE238047T1
ATE238047T1 AT98941201T AT98941201T ATE238047T1 AT E238047 T1 ATE238047 T1 AT E238047T1 AT 98941201 T AT98941201 T AT 98941201T AT 98941201 T AT98941201 T AT 98941201T AT E238047 T1 ATE238047 T1 AT E238047T1
Authority
AT
Austria
Prior art keywords
phenylcarbamoylmethyl
bis
derivatives
treatment
dimethylammonium chloride
Prior art date
Application number
AT98941201T
Other languages
English (en)
Inventor
Bernard A Macleod
David M J Quastel
Original Assignee
Ucb Farchim Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ucb Farchim Sa filed Critical Ucb Farchim Sa
Application granted granted Critical
Publication of ATE238047T1 publication Critical patent/ATE238047T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT98941201T 1997-09-03 1998-09-03 Verwendung von n,n-bis (phenylcarbamoylmethyl) dimethylammoniumchlorid und derivaten davon zur behandlung von chronischem schmerz ATE238047T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5631297P 1997-09-03 1997-09-03
PCT/CA1998/000842 WO1999011252A2 (en) 1997-09-03 1998-09-03 N,n-bis (phenylcarbamoylmethyl) dimethylammonium chloride and derivatives in the treatment of pain

Publications (1)

Publication Number Publication Date
ATE238047T1 true ATE238047T1 (de) 2003-05-15

Family

ID=22003584

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98941201T ATE238047T1 (de) 1997-09-03 1998-09-03 Verwendung von n,n-bis (phenylcarbamoylmethyl) dimethylammoniumchlorid und derivaten davon zur behandlung von chronischem schmerz

Country Status (12)

Country Link
EP (1) EP1009397B1 (de)
JP (1) JP2001514216A (de)
CN (1) CN1276722A (de)
AT (1) ATE238047T1 (de)
AU (1) AU8970198A (de)
BR (1) BR9812182A (de)
CA (1) CA2303815A1 (de)
DE (1) DE69813839T2 (de)
ES (1) ES2197500T3 (de)
HK (1) HK1028957A1 (de)
TW (1) TW536401B (de)
WO (1) WO1999011252A2 (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ507169A (en) 1998-04-01 2004-02-27 Cardiome Pharma Corp Aminocyclohexyl ether compounds and uses thereof
BR9911094A (pt) * 1998-06-09 2001-10-30 Nortran Pharmaceuticals Inc Composições e métodos para o tratamento detosse
US7507545B2 (en) 1999-03-31 2009-03-24 Cardiome Pharma Corp. Ion channel modulating activity method
US7057053B2 (en) 2000-10-06 2006-06-06 Cardiome Pharma Corp. Ion channel modulating compounds and uses thereof
US7524879B2 (en) 2000-10-06 2009-04-28 Cardiome Pharma Corp. Ion channel modulating compounds and uses thereof
BRPI0318278B8 (pt) 2003-05-02 2024-01-09 Cardiome Pharma Corp Compostos de éter aminocicloexílico, composição compreendendo ditos compostos, usos dos mesmos e método para modular a atividade do canal iônico em um ambiente in vitro
US7345086B2 (en) 2003-05-02 2008-03-18 Cardiome Pharma Corp. Uses of ion channel modulating compounds
WO2005018635A2 (en) 2003-08-07 2005-03-03 Cardiome Pharma Corp. Ion channel modulating activity i
US7345087B2 (en) 2003-10-31 2008-03-18 Cardiome Pharma Corp. Aminocyclohexyl ether compounds and uses thereof
WO2005097087A2 (en) 2004-04-01 2005-10-20 Cardiome Pharma Corp. Merged ion channel modulating compounds and uses thereof
WO2005113011A2 (en) 2004-04-01 2005-12-01 Cardiome Pharma Corp. Prodrugs of ion channel modulating compounds and uses thereof
US8263638B2 (en) 2004-11-08 2012-09-11 Cardiome Pharma Corp. Dosing regimens for ion channel modulating compounds
EP2101819B1 (de) 2006-11-20 2013-01-09 President and Fellows of Harvard College Verfahren, zusammensetzungen und sets zur behandlung von schmerzen und pruritis
CN102725401A (zh) 2009-07-10 2012-10-10 哈佛大学校长及研究员协会 作为抗炎药的永久带电荷的钠和钙通道阻断剂
JP6833811B2 (ja) 2015-08-03 2021-02-24 プレジデント アンド フェローズ オブ ハーバード カレッジ 荷電イオンチャネル遮断薬及び使用方法
JP2022527690A (ja) 2019-03-11 2022-06-03 ノシオン セラピューティクス，インコーポレイテッド 荷電したイオンチャンネル遮断薬および使用方法
US10828287B2 (en) 2019-03-11 2020-11-10 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
CN113811305A (zh) 2019-03-11 2021-12-17 诺西恩医疗公司 带电的离子通道阻滞剂及其使用方法
CA3129089A1 (en) 2019-03-11 2020-09-17 Bridget Mccarthy Cole Ester substituted ion channel blockers and methods for use
US10780083B1 (en) 2019-03-11 2020-09-22 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
US10933055B1 (en) 2019-11-06 2021-03-02 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
WO2021091585A1 (en) 2019-11-06 2021-05-14 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
CA3170070A1 (en) 2020-03-11 2021-09-16 Bridget Mccarthy Cole Charged ion channel blockers and methods for use
WO2023100836A1 (ja) * 2021-11-30 2023-06-08 マルホ株式会社 医薬組成物
JP7273257B1 (ja) * 2021-11-30 2023-05-12 マルホ株式会社 医薬組成物

Also Published As

Publication number Publication date
EP1009397A2 (de) 2000-06-21
ES2197500T3 (es) 2004-01-01
CA2303815A1 (en) 1999-03-11
HK1028957A1 (en) 2001-03-16
TW536401B (en) 2003-06-11
BR9812182A (pt) 2002-01-15
WO1999011252A3 (en) 1999-05-06
WO1999011252A2 (en) 1999-03-11
EP1009397B1 (de) 2003-04-23
JP2001514216A (ja) 2001-09-11
DE69813839T2 (de) 2004-03-04
DE69813839D1 (de) 2003-05-28
CN1276722A (zh) 2000-12-13
AU8970198A (en) 1999-03-22

Similar Documents

Publication Publication Date Title
ATE238047T1 (de) Verwendung von n,n-bis (phenylcarbamoylmethyl) dimethylammoniumchlorid und derivaten davon zur behandlung von chronischem schmerz
DE59609235D1 (de) Verwendung von aerogelen in der landwirtschaft
DE69941586D1 (de) Verwendung von Uridin in Kombination mit Cholin zur Behandlung von Gedächtnisstörungen
DE3483040D1 (de) Maschinelesbares dokument und dessen behandlung.
ATE256463T1 (de) Pharmazeutische zubereitung zur verwendung in der behandlung von diabetes
DE69927971D1 (de) Verwendung von peg-ifn-alpha und ribavirin zur behandlung chronischer hepatitis c
DE69230046T2 (de) 2-Bromomelatonin zur Behandlung von Schlafstörungen
DE69739758D1 (de) Vakzine zur behandlung von lymphomen und leukämie
ATE246197T1 (de) Neue heteroaromatische fructose 1,6- bisphosphatase inhibitoren
DE60321929D1 (de) Pharmazeutische zusammensetzungen mit dextromethorphan und chinidin zur behandlung von neurologischen erkrankungen
DE3777812D1 (de) T-gatterelektrode fuer feldeffekttransistor und dadurch hergestellter feldeffekttransistor.
ATE81978T1 (de) Verwendung von 3'-azido-3'-deoxythymidin zur behandlung oder vorbeugung von menschlichen retrovirus-infektionen.
DE69421778D1 (de) Verwendung von wirksamen Mengen von aktiven Stoffen zur Behandlung von Mischhaut
DE69212620T2 (de) Verwendung von Glycosaminoglycanen zur Behandlung von diabetischer Nephropathie und diabetischer Neuropathie
GR3006073T3 (de)
IS5504A (is) Samsetning virk við meðhöndlun á getuleysi
ATE292975T1 (de) Verwendung von tetrahydolipstatin in der behandlung von diabetes typ ii
DE50007706D1 (de) Verwendung von melatonin zur behandlung der androgenetischen und diffusen alopezie vom weiblichen typ
DE3850433D1 (de) Allergiebehandlung und Zusammensetzung dafür.
DE60027429D1 (de) Dihydrobenzodiazepinen und deren verwendung zur behandlung von dyslipidämien
BR0014372A (pt) Derivados de 5-hidroxissapogenina com atividade antidemência
FI973185A0 (fi) Melatoniinin käyttö lääkeriippuvuudesta kärsivien potilaiden hoitoon
DE69936779D1 (de) Verwendung von ngali nussöl zur behandlung/linderung der arthritisschmerzen und anderer ähnlichen störungen
DE69300037T2 (de) Verwendung von Bucillamin zur Herstellung eines Arzneimittels zur Behandlung von Cystinuria.
DE69110861T2 (de) Mittel zur verbesserung des kollagenmetabolismus und dessen verwendung.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties